Tarsus Pharmaceuticals TARS
NASDAQ TARS
$73.34 +2.50 (+3.53%)
As of: Nov 10, 2026 · 2:21 PM EST

Tarsus Pharmaceuticals (TARS) Net Long-Term Debt Issued (Repaid) (2019 - 2024)

Updated

Tarsus Pharmaceuticals' Net Long-Term Debt Issued (Repaid) was $75 million in FY2024, up 650.0% from $10 million in FY2023.

Analysis

Tarsus Pharmaceuticals (TARS) Net Long-Term Debt Issued (Repaid) (2019 - 2024) Analysis & Trends

From FY2019 onward, Tarsus Pharmaceuticals has reported Net Long-Term Debt Issued (Repaid) for 4 years.

  • Net Long-Term Debt Issued (Repaid) shows a five-year compound annual growth rate of 106.7% (FY2019 to FY2024).
  • Per Business Quant data, Net Long-Term Debt Issued (Repaid) in earlier years was $10 million in FY2023 (-50.0%) and $20 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net LT Debt (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -1.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 9.98 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -19.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Tarsus Pharmaceuticals 3.35 Bn 2.41 Bn 180.68 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 75.00 Mn
Sep 30, 2023 5.00 Mn
Mar 31, 2023 5.00 Mn
Mar 31, 2022 20.00 Mn
Dec 31, 2019 989,000.00
API Access

Tarsus Pharmaceuticals Net Long-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=TARS&period=max&api_key=YOUR_API_KEY